Monograph

M02AA10 - Ketoprofen

Not porphyrinogenic

Rationale

Insignificant systemic exposure. Two references consider it (probably) safe. Did not induce ALAS1 in rat.

Chemical description

Gel 2.5%. Analgetic and antiinflammatory gel for dermal application. Bioavailability after percutaneous administration about 5%. South African list: use with care. French list: authorized

IPNet drug reports

Uneventful use reported in 19 patients with acute porphyria.

Similar drugs

Explore alternative drugs in similar therapeutic classes M02A / M02AA or go back.

Tradenames and packages

From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.

Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.

Belgium

Fastum · Fastum 2.5 % (Impexeco) gel · Fastum 2.5 % (Impexeco) gel pompe dos. · Fastum 2.5 % gel · Fastum 2.5 % gel pompe dos.

United Kingdom

Ketoprofen · Ketoprofen 10% gel · Ketoprofen 2.5% gel · Oruvail · Oruvail 2.5% gel · Powergel · Powergel 2.5% gel · Tiloket · Tiloket 2.5% gel

Norway

Orudis

Poland

Fastum · Ketonal · Ketoprofen LGO · Ketoprofen Ziaja · Ketoprofenum Fastum · Ketospray forte · Opokan-keto · Ultrafastin

Luxembourg

FASTUM

Finland

Orudis

Latvia

Begsan · Fastum

Serbia

Artrocol · Artrocol® · Fastum · Fastum® Gel · Ketonal · Ketonal®

Acute Porphyria Drug Database

Monograph